Human coronavirus NL63, a new respiratory virus

FEMS Microbiology Reviews

Volumn 30, Issue 5, 2006, Pages 760-773

  Van Der Hoek, Lia ^a   Pyrc, Krzysztof ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

ACE2; Croup; HCoV NL63; Human coronavirus; Kawasaki disease; Respiratory tract illness

Indexed keywords

AZAURIDINE; BETA DEXTRO N4 HYDROXYCYTIDINE; CYTIDINE DERIVATIVE; IMMUNOGLOBULIN; M PROTEIN; PEPTIDE; PROTEIN HR2; PYRIMIDINE NUCLEOSIDE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

CORONAVIRUS; HUMAN; HUMAN CORONAVIRUS NL63; LUNG INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SARS CORONAVIRUS; SEASONAL VARIATION; SEROPREVALENCE; VIRUS CULTURE; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS NUCLEOCAPSID; VIRUS SHEDDING; VIRUS STRAIN;

CORONAVIRUS; CORONAVIRUS INFECTIONS; HUMANS; RESPIRATORY TRACT INFECTIONS; SEASONS; TRANSCRIPTION, GENETIC; VIRUS REPLICATION; VIRUS SHEDDING;

CORONAVIRUS; SARS CORONAVIRUS;

EID: 33746908129     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1111/j.1574-6976.2006.00032.x     Document Type: Review

References (78)

1. Arden KE, Nissen MD, Sloots TP & Mackay IM (2005) New human coronavirus HCoV-NL63 associated with severe lower respiratory tract disease in Australia. J Med Virol 75: 455-462.
2. Bastien N, Anderson K, Hart L, Van Caeseele P, Brandt K, Milley D, Hatchette T, Weiss EC & Li Y (2005a) Human coronavirus NL63 infection in Canada. J Infect Dis 191: 503-506.
3. Bastien N, Robinson JL, Tse A, Lee BE, Hart L & Li Y (2005b) Human coronavirus NL-63 infections in children: a 1-year study. J Clin Microbiol 43: 4567-4573.
4. Belay ED, Erdman DD, Anderson LJ, Peret TC, Schrag SJ, Fields BS, Burns JC & Schonberger LB (2005) Kawasaki disease and human coronavirus. J Infect Dis 192: 352-353.
5. Blau DM & Holmes KV (2001) Human coronavirus HCoV-229E enters susceptible cells via the endocytic pathway. Adv Exp Med Biol 494: 193-198.
6. Bosch BJ, Martina BE, van der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, de Groot R, Osterhaus AD & Rottier PJ (2004) Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc Natl Acad Sci USA 101: 8455-8460.
7. Bradburne AF, Bynoe ML & Tyrrell DA (1967) Effects of a 'new' human respiratory virus in volunteers. Br Med J 3: 767-769.
8. Burns JC (2001) Kawasaki disease. Adv Pediatr 48: 157-177.
9. Burns JC & Glode MP (2004) Kawasaki syndrome. Lancet 364: 533-544.
10. Chang LY, Chiang BL, Kao CL, Wu MH, Chen PJ, Berkhout B, Yang HC & Huang LM (2006) Lack of association between infection with a novel human coronavirus (HCoV) HCoV-NH and Kawasaki Disease in Taiwan. J Infect Dis 193: 283-286.
11. Chiu SS, Chan KH, Chu KW, Kwan SW, Guan Y, Poon LL & Peiris JS (2005) Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong China. Clin Infect Dis 40: 1721-1729.
12. Delmas B, Gelfi J, L'Haridon R, Vogel LK, Sjostrom H, Noren O & Laude H (1992) Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 357: 417-420.
13. Domingo E (2002) Quasispecies theory in virology. J Virol 76: 463-465.
14. Drake JW & Holland JJ (1999) Mutation rates among RNA viruses. Proc Natl Acad Sci USA 96: 13910-13913.
15. Drosten C, Gunther S, Preiser W, et al. (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348: 1967-1976.
16. Ebihara T, Endo R, Ma X, Ishiguro N & Kikuta H (2005a) Detection of human coronavirus NL63 in young children with bronchiolitis. J Med Virol 75: 463-465.
17. Ebihara T, Endo R, Ma X, Ishiguro N & Kikuta H (2005b) Lack of association between New Haven coronavirus and Kawasaki disease. J Infect Dis 192: 351-352.
18. Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML & Kahn JS (2005a) Association between a novel human coronavirus and Kawasaki Disease. J Infect Dis 191: 499-502.
19. Esper F, Weibel C, Ferguson D, Landry ML & Kahn JS (2005b) Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J Infect Dis 191: 492-498.
20. Forster J, Ihorst G, Rieger CH, et al. (2004) Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI DE study). Eur J Pediatr 163: 709-716.
21. Fouchier RA, Hartwig NG, Bestebroer TM, Niemeyer B, de Jong JC, Simon JH & Osterhaus AD (2004) A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci USA 101: 6212-6216.
22. Haasnoot PCJ, Cupac D & Berkhout B (2003) Inhibition of virus replication by RNA interference. J Biomed Sci 10: 607-616.
23. Hamre D & Procknow JJ (1966) A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 121: 190-193.
24. Hemming VG, Rodriguez W, Kim HW, Brandt CD, Parrott RH, Burch B, Prince GA, Baron PA, Fink RJ & Reaman G (1987) Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother 31: 1882-1886.
25. Hendley JO, Fishburne HB & Gwaltney JM Jr (1972) Coronavirus infections in working adults. Eight-year study with 229 E and OC 43. Am Rev Respir Dis 105: 805-811.
26. Herrewegh AA, Mahler M, Hedrich HJ, Haagmans BL, Egberink HF, Horzinek MC, Rottier PJ & de Groot RJ (1997) Persistence and evolution of feline coronavirus in a closed cat-breeding colony. Virology 234: 349-363.
27. Herrewegh AA, Smeenk I, Horzinek MC, Rottier PJ & de Groot RJ (1998) Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol 72: 4508-4514.
28. Hofmann H, Hattermann K, Marzi A, Gramberg T, Geier M, Krumbiegel M, Kuate S, Uberla K, Niedrig M & Pohlmann S (2004) S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol 78: 6134-6142.
29. Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout B & Pohlmann S (2005) Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci USA 102: 7988-7993.
30. Huang IC, Bosch BJ, Li F, et al. (2005) SARS coronavirus but not human coronavirus NL63 utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem 281: 3198-3203.
31. Imai Y, Kuba K, Rao S, et al. (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436: 112-116.
32. Kaiser L, Regamey N, Roiha H, Deffernez C & Frey U (2005) Human coronavirus NL63 associated with lower respiratory tract symptoms in early life. Pediatr Infect Dis J 24: 1015-1017.
33. Konig B, Konig W, Arnold R, Werchau H, Ihorst G & Forster J (2004) Prospective study of human metapneumovirus infection in children less than 3 years of age. J Clin Microbiol 42: 4632-4635.
34. Ksiazek TG, Erdman D, Goldsmith CS, et al. (2003) A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348: 1953-1966.
35. Kuba K, Imai Y, Rao S, et al. (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 11: 875-879.
36. Kuijpers TW, Wiegman A, van Lier RA, Roos MT, Wertheim-van Dillen PM, Pinedo S & Ottenkamp J (1999) Kawasaki disease: a maturational defect in immune responsiveness. J Infect Dis 180: 1869-1877.
37. Lai MMC & Holmes KV (2001) Coronaviridae: the viruses and their replication. Fields Virology (Knipe DM & Howley PM, eds), pp. 1163-1186. Lippincott Williams & Wilkins, Philadelphia.
38. Lai MM, Baric RS, Makino S, Keck JG, Egbert J, Leibowitz JL & Stohlman SA (1985) Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol 56: 449-456.
39. Larson HE, Reed SE & Tyrrell DA (1980) Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol 5: 221-229.
40. Lau SK, Woo PC, Li KS, Huang Y, Tsoi HW, Wong BH, Wong SS, Leung SY, Chan KH & Yuen KY (2005) Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci USA 102: 14040-14045.
41. Li W, Moore MJ, Vasilieva N, et al. (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426: 450-454.
42. Li W, Shi Z, Yu M, et al. (2005) Bats are natural reservoirs of SARS-like coronaviruses. Science 310: 676-679.
43. Lim KP & Liu DX (1998) Characterization of the two overlapping papain-like proteinase domains encoded in gene 1 of the coronavirus infectious bronchitis virus and determination of the C-terminal cleavage site of an 87-kDa protein. Virology 245: 303-312.
44. Liu W, Tang F, Fontanet A, et al. (2004) Long-term SARS coronavirus excretion from patient cohort China. Emerg Infect Dis 10: 1841-1843.
45. Macnaughton MR, Madge MH & Reed SE (1981) Two antigenic groups of human coronaviruses detected by using enzyme-linked immunosorbent assay. Infect Immun 33: 734-737.
46. McIntosh K (1996) Coronaviruses. Fields virology (Fields BN, Knipe DM & Howley PM, et al., eds), 1095 pp. Lippincott-Raven Publishers, Philadelphia.
47. McIntosh K, Dees JH, Becker WB, Kapikian AZ & Chanock RM (1967) Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci USA 57: 933-940.
48. McIntosh K, Chao RK, Krause HE, Wasil R, Mocega HE & Mufson MA (1974) Coronavirus infection in acute lower respiratory tract disease of infants. J Infect Dis 130: 502-507.
49. Moes E, Vijgen L, Keyaerts E, Zlateva K, Li S, Maes P, Pyrc K, Berkhout B, van der Hoek L &Van Ranst M (2005) A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect Dis 5: 6.
50. Moya A, Holmes EC & Gonzalez-Candelas F (2004) The population genetics and evolutionary epidemiology of RNA viruses. Nat Rev Microbiol 2: 279-288.
51. Osterhaus AD, Fouchier RA & Kuiken T (2004) The aetiology of SARS: Koch's postulates fulfilled. Philos Trans R Soc London B Biol Sci 359: 1081-1082.
52. Pinon JD, Teng H & Weiss SR (1999) Further requirements for cleavage by the murine coronavirus 3C-like proteinase: identification of a cleavage site within ORF1b. Virology 263: 471-484.
53. Poon LL, Chu DK, Chan KH, et al. (2005) Identification of a novel coronavirus in bats. J Virol 79: 2001-2009.
54. Pyrc K, Jebbink MF, Berkhout B & van der Hoek L (2004) Genome structure and transcriptional regulation of human coronavirus NL63. Virol J 1: 7.
55. Pyrc K, Berkhout B & van der Hoek L (2005) Molecular characterization of human coronavirus NL63. Recent Research Developments in Infection & Immunity (Pandelai SG, ed.), pp. 25-48. Transworld Research Network, Kerala, India.
56. Pyrc K, Bosch BJ, Berkhout B, Jebbink MF, Dijkman R, Rottier P & van der Hoek L (2006a) Inhibition of HCoV-NL63 infection at early stages of the replication cycle. Antimicrob Agents Chemother 50: 2000-2008.
57. Reed SE (1984) The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: evidence of heterogeneity among 229E-related strains. J Med Virol 13: 179-192.
58. Shimizu C, Shike H, Baker SC, et al. (2005) Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki Disease. J Infect Dis 192: 1767-1771.
59. Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ & Bates P (2004) Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci USA 101: 4240-4245.
60. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL & Bates P (2005) Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci USA 102: 11876-11881.
61. Sims AC, Baric RS, Yount B, Burkett SE, Collins PL & Pickles RJ (2005) Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol 79: 15511-15524.
62. Sloots TP, McErlean P, Speicher DJ, Arden KE, Nissen MD & Mackay IM (2006) Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J Clin Virol 35: 99-102.
63. Stephensen CB, Casebolt DB & Gangopadhyay NN (1999) Phylogenetic analysis of a highly conserved region of the polymerase gene from 11 coronaviruses and development of a consensus polymerase chain reaction assay. Virus Res 60: 181-189.
64. Stiehm ER, Ashida E, Kim KS, Winston DJ, Haas A & Gale RP (1987) Intravenous immunoglobulins as therapeutic agents. Ann Intern Med 107: 367-382.
65. Suzuki A, Okamoto M, Ohmi A, Watanabe O, Miyabayashi S & Nishimura H (2005) Detection of human coronavirus-NL63 in children in Japan. Pediatr Infect Dis J 24: 645-646.
66. Tresnan DB, Levis R & Holmes KV (1996) Feline aminopeptidase N serves as a receptor for feline canine porcine and human coronaviruses in serogroup I. J Virol 70: 8669-8674.
67. Tyrrell DAJ & Bynoe ML (1965) Cultivation of novel type of common-cold virus in organ cultures. Br Med J 1: 1467-1470.
68. Vabret A, Mourez T, Dina J, van der Hoek L, Gouarin S, Petitjean J, Brouard J & Freymuth F (2005) Human coronavirus NL63 France. Emerg Infect Dis 11: 1225-1229.
69. Vabret A, Dina J, Gouarin S, Petitjean J, Corbet S & Freymuth F (2006) Detection of the new human coronavirus HKU1: a report of 6 cases. Clin Infect Dis 42: 634-639.
70. van der Hoek L & Berkhout B (2005) Questions concerning the New Haven coronavirus. J Infect Dis 192: 350-351.
71. van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC, Wertheim-van Dillen PM, Kaandorp J, Spaargaren J & Berkhout B (2004) Identification of a new human coronavirus. Nat Med 10: 368-373.
72. van der Hoek L, Sure K, Ihorst G, Stang A, Pyrc K, Jebbink MF, Petersen G, Forster J, Berkhout B & Uberla K (2005) Croup is associated with the novel coronavirus NL63. PLoS Med 2: e240.
73. van Elden LJ, van Loon AM, van Alphen F, Hendriksen KA, Hoepelman AI, van Kraaij MG, Oosterheert JJ, Schipper P, Schuurman R & Nijhuis M (2004) Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction. J Infect Dis 189: 652-657.
74. Woo PC, Huang Y, Lau SK, Tsoi HW & Yuen KY (2005a) In silico analysis of ORF1ab in coronavirus HKU1 genome reveals a unique putative cleavage site of coronavirus HKU1 3C-like protease. Microbiol Immunol 49: 899-908.
75. Woo PC, Lau SK, Chu CM, et al. (2005b) Characterization and complete genome sequence of a novel coronavirus HKU1 from patients with pneumonia. J Virol 79: 884-895.
76. Woo PC, Lau SK, Tsoi HW, et al. (2005c) Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. J Infect Dis 192: 1898-1907.
77. Yang H, Xie W, Xue X, et al. (2005) Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol 3: e324.
78. Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT & Holmes KV (1992) Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357: 420-422.